Amrutkar M, Li Y, Finstadsveen AV, Verbeke CS, Gladhaug IP(2025) Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine 13(4) DOI 10.3390/proteomes13040048, PubMed 41133621
Farnes I, Verbeke CS, Kleive D, Waage A, Tholfsen T, Hagen M, Fosby B, Line PD, Labori KJ(2025) Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer 17(15) DOI 10.3390/cancers17152505, PubMed 40805202
Abu Hilal M, Uijterwijk BA, Lemmers DHL, Janssen BV, Besselink MG, Bianchi D, Fariña A, Fukushima N, Gill AJ, Hong SM, Krasinskas A, Luchini C, Melocchi L, Rossi G, Scarpa A, Basturk O, Chatterjee D, Chou A, Esposito I, Feakins R, Groot Koerkamp B, Hruban RH, La Rosa S, Shi C, Singhi Aet al.(2025) The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN) 13(7), 1048-1068 DOI 10.1002/ueg2.70074, PubMed 40729532
